Trends and Components of Thyroid Status Evaluation in Commercially Insured Adults in the United States, 2006-2020
Authors' conclusion
TSH testing rates among commercially insured individuals without known thyroid disease appears stable over time, with higher frequency in females and with increasing age.
Study context
- Population
- Adults 18–64 years old without evidence of thyroid disease with ≥365 days of continuous enrollment, 2006–2020, IBM MarketScan Claims Database15,138,211 with ≥1 thyroid-stimulating hormone (TSH) test
- Participants
- 67,353,280 adults
- Outcome
- Trends of TSH tests/1000 eligible patient-months stratified by age, sex and region, and composition of thyroid function testing
- Follow-up
- 2006-2020
Methodological detailsclaims database analysis
- Claims database analysis
Main finding
As reported in the abstract
TSH testing rates
- TSH tests identified
- 25 606 518
- TSH tests/1000 person-months, first study month
- 11.4
- TSH tests/1000 person-months, last study month
- 11.7
- Mean TSH tests/1000 person-months
- 12.2
- TSH testing rate, spring 2020 (sharp drop), tests/1000 person-months
- 4.2
- Females, TSH tests/1000 person-months
- 16.1
- Males, TSH tests/1000 person-months
- 8.6
- Age 18-34 years, TSH tests/1000 person-months
- 8.2
- Age 55-64 years, TSH tests/1000 person-months
- 15.4
- Thyroid function testing episodes including only TSH
- 70.8%
Observational data: associations, not effects.
Further findings
Characteristics of patients contributing a TSH testing episode
- Aged 45-54 years
- 29.8%
- Female
- 63.6%
Original publication
Trends and Components of Thyroid Status Evaluation in Commercially Insured Adults in the United States, 2006-2020. J Clin Endocrinol Metab. Published 27 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →